Did you mean 10 19 8?
Displaying drugs 2051 - 2075 of 3088 in total
Sarconeos
Sarconeos is an activator of the MAS receptor.
Investigational
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Empasiprubart
Empasiprubart is a humanized sweeping antibody designed to bind to C2, a protein in the complement cascade that leads to cell destruction when activated.
Investigational
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
PLN-74809
PLN-74809 is a small-molecule that dually inhibits both αvβ6 and αvβ1 to treat both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC) . The compound was granted orphan drug designation by the US FDA in August 2018 for treatment of IPF, and Pliant Therapeutics recently raised $100 million in...
Investigational
Matched Description: … designation by the US FDA in August 2018 for treatment of IPF, and Pliant Therapeutics recently raised $100 ... addition, the compound is also currently in Phase 2a trials (NCT04565249) for the treatment of COVID-19 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Soneclosan
Experimental
ADX10059
ADX10059 is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). The orally available small molecule drug candidate, which is highly specific for mGluR5, was discovered at Addex in 2003. It is developed for the treatment of GERD, migraine and anxiety.
Investigational
NUC B1000
NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct designed to produce four short interfering RNA (siRNA) molecules, formulated with a proprietary cationic-lipid delivery system. eiRNA is an approach to RNAi therapeutics, whereby a plasmid DNA coding for desired dsRNA is delivered to...
Investigational
Pranlukast
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
Investigational
Matched Iupac: … N-[4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide …
Matched Products: … PRANLUX 100 MG SAŞE, 30 SAŞE ... PRANLUX 100 MG SAŞE, 90 SAŞE …
Matched Products: … PRANLUX 100 MG SAŞE, 30 SAŞE ... PRANLUX 100 MG SAŞE, 90 SAŞE …
Nifuroxazide
Experimental
Matched Mixtures name: … METRONIDAZOL/NIFUROXAZIDA 300 MG/100 MG. …
Matched Products: … KOFURIL 100 MG KAPSÜL 30 ADET ... KOFURIL 100 MG KAPSÜL, 12 ADET ... DIAFURYL 100 MG KAPSUL, 12 ADET …
Matched Products: … KOFURIL 100 MG KAPSÜL 30 ADET ... KOFURIL 100 MG KAPSÜL, 12 ADET ... DIAFURYL 100 MG KAPSUL, 12 ADET …
VTP-194204
Nrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.
Investigational
LAS-191954
Investigational
LDN-193189
Investigational
Cymarin
Experimental
PPI-1040
Investigational
Vilobelimab
Vilobelimab is a chimeric monoclonal immunoglobulin G4 (IgG4) antibody that binds to the soluble form of human C5a with high affinity. It consists of mouse anti-human complement factor 5a (C5a) monoclonal binding sites (variable regions of heavy and light chain regions) and human gamma 4 heavy chain and light kappa...
Investigational
Matched Description: … 2023, the FDA issued an emergency use authorization (EUA) for vilobelimab for the treatment of COVID-19 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
NS-8593
Experimental
Tea tree oil
Tea tree oil is an essential oil derived mainly from the Australian native plant Melaleuca alternifolia via steam distillation of the of the leaves and terminal branches . It may be referred to as Melaleuca alternifolia oil. It has been a popular ingredient in a variety of household and cosmetic...
Experimental
Nutraceutical
Matched Products: … T40-C5 - Liq 100% ... T36-C7 - Liq 100% …
Rivanicline
Rivanicline (TC-2403, RJR-2403, (E)-metanicotine) is a partial agonist at neuronal nicotinic acetylcholine receptors, binding primarily to the α4β2 subtype. It was originally developed as a potential treatment for Alzheimer's disease for its nootropic effects but has also been found to inhibit the production of Interleukin-8. It has subsequently been developed...
Investigational
Matched Description: … disease for its nootropic effects but has also been found to inhibit the production of Interleukin-8. …
Lipotecan
Investigational
Matched Iupac: … (19S)-8-[(dimethylamino)methyl]-19-ethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{ ... 2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-19-yl 2-{[(2,4,5,7-tetranitro-9H-fluoren …
TST10088
TST10088 is a recombinant variant of a plant toxin belonging to the family of class II ribosome inactivating proteins. These molecules efficiently kill cells by activating preprogrammed death pathways known as apoptosis. TST10088 has been designed and engineered by Twinstrand to contain a peptide switch that is specifically cleaved by...
Investigational
Butamirate
Experimental
Matched Products: … CODACTIV 7,5 MG/5 ML SURUP, 100 ML ... TAMIRAL 7,5 MG / 5 ML SURUP 100 ML ... SOLMIRAT 7,5 MG / 5 ML SURUP,100 ML …
Clostridium botulinum
Experimental
Matched Products: … NEURONOX LYOPHILIZED POWDER FOR INJECTION 100 UNITS/VIAL ... Xeomin 100 Einheiten Pulver zur Herstellung einer Injektionslösung ... BOCOUTURE 100 Einheiten Pulver zur Herstellung einer Injektionslösung …
FLT190
FLT190 is a recombinant adeno-associated viral vector serotype S3 containing DNA encoding for human alpha-galactosidase A.
Investigational
Prolectin-M
Prolectin-M is a (1-6)-alpha-D-mannopyranose and acts as an antagonist of galectin. It is being investigated in the clinical trial NCT04512027 (Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. (Prolectin-M)).
Investigational
Matched Description: … [L31343] It is being investigated in the clinical trial NCT04512027 (Prolectin-M in COVID-19 Patients …
RAPA-501-Allo
RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed ex vivo in a process that involves de-differentiation and re-differentiation.
Investigational
Displaying drugs 2051 - 2075 of 3088 in total